For those who are fretting over efficacy not being

For those who are fretting over efficacy not being good enough. The latest PR doesn't say the submittal for EUA for U.S./UK is conditional on potential results from the trial. It says it will be submitted, which tells you all about confidence they have in the data.

Quote:

---

COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week

---